GSK malpractice case raises questions about trial standards

Original article by: N Fuertes

Reference: Lancet 11 Feb 2012;379(9815):508

Source: Lancet

Keywords: America-Southern; Child; Clinical Trials; Developing Countries; Drug Industry; Informed Consent; Litigation; Parents; Vaccines;

Date published: 10/02/2012 08:15

Summary
by: Pharm-line

News report concerning ongoing legal action in Argentina regarding informed consent from parents of children taking part in a trial assessing the efficacy and safety of Synflorix, a vaccine against Streptococcus pneumoniae and acute otitis media caused by non-typeable Haemophilus influenzae manufactured by GlaxoSmithKline.

About this library entry

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.